Search hospitals > Indiana > Lafayette
Franciscan Saint Elizabeth Health - Lafayette East
Claim this profileLafayette, Indiana 47905
Conducts research for Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Colorectal Cancer
19 reported clinical trials
4 medical researchers
Summary
Franciscan Saint Elizabeth Health - Lafayette East is a medical facility located in Lafayette, Indiana. This center is recognized for care of Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma, Colorectal Cancer and other specialties. Franciscan Saint Elizabeth Health - Lafayette East is involved with conducting 19 clinical trials across 49 conditions. There are 4 research doctors associated with this hospital, such as Meghana Raghavendra, Taylor M. Ortiz, Harsha Ranganath, and Naveed A. Rana.Area of expertise
1Cancer
Stage III
Stage IV
HER2 positive
2Breast Cancer
Stage IV
HER2 positive
ER positive
Top PIs
Meghana RaghavendraFranciscan Health Indianapolis5 years of reported clinical research
Studies Colorectal Cancer
Studies Adenocarcinoma
12 reported clinical trials
28 drugs studied
Taylor M. OrtizFranciscan Health Indianapolis1 year of reported clinical research
Studies Cancer
Studies Breast Cancer
7 reported clinical trials
19 drugs studied
Harsha RanganathFranciscan Health Mooresville1 year of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
5 reported clinical trials
11 drugs studied
Naveed A. RanaFranciscan Health Indianapolis6 years of reported clinical research
Studies Breast Cancer
Studies Brain Metastasis
4 reported clinical trials
8 drugs studied
Clinical Trials running at Franciscan Saint Elizabeth Health - Lafayette East
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Colorectal Cancer
Squamous Cell Carcinoma
ALK Gene Rearrangement
Brain Metastasis
Tumors
Cardiotoxicity
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Franciscan Saint Elizabeth Health - Lafayette East?
Franciscan Saint Elizabeth Health - Lafayette East is a medical facility located in Lafayette, Indiana. This center is recognized for care of Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma, Colorectal Cancer and other specialties. Franciscan Saint Elizabeth Health - Lafayette East is involved with conducting 19 clinical trials across 49 conditions. There are 4 research doctors associated with this hospital, such as Meghana Raghavendra, Taylor M. Ortiz, Harsha Ranganath, and Naveed A. Rana.